Revenues dropped 13% to $53.6 million for SonoSite in the third quarter compared with the year earlier period.
SonoSite revenues drop in 3Q
Revenues dropped 13% to $53.6 million for SonoSite in the third quarter compared with the year earlier period. The most recent quarter showed a deteriorating marketplace for the pioneer of hand-carried ultrasound as nine month revenues were down 9% compared with the first nine months of 2008. Foreign exchange had zero effect on third quarter revenue, according to the company, but a negative impact of $6.7 million or 4% for the nine months just ended. For the third quarter of 2009, the company recorded a net loss of $0.2 million compared with a net income of $3.7 million in 2008. For the nine months of 2009, net income was $1.0 million compared with $5.3 million. Kevin M. Goodwin, SonoSite president and CEO, said U.S. revenue levels continued to stabilize and the company ran into “a few” order delays in its international business. Importantly, he said, pricing and expense management have improved, resulting in steadily increasing operating margin performance.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.